Esmé Eggink

ORCID: 0000-0001-7132-2937
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Mobile Health and mHealth Applications
  • Nutritional Studies and Diet
  • Health disparities and outcomes
  • Blood Pressure and Hypertension Studies
  • Technology Use by Older Adults
  • Anesthesia and Sedative Agents
  • Substance Abuse Treatment and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Crime Patterns and Interventions
  • Pharmaceutical Practices and Patient Outcomes
  • Psychopathy, Forensic Psychiatry, Sexual Offending
  • Digital Mental Health Interventions
  • Cardiac, Anesthesia and Surgical Outcomes
  • Patient Safety and Medication Errors
  • Intergenerational Family Dynamics and Caregiving
  • Renin-Angiotensin System Studies
  • Nutrition and Health in Aging

University of Amsterdam
2014-2025

Amsterdam University Medical Centers
2019-2025

Radboud University Nijmegen
2022

Radboud University Medical Center
2022

University Medical Center
2019

Reinier van Arkel
2019

Arkin
2019

Modifiable risk factors have been linked to 45% of dementia cases. Mobile health (mHealth) interventions targeting lifestyle-related with remote coaching the potential reach underserved high-risk populations globally. To date, little is known about implementation such in China. Fifty semi-structured interviews were conducted 14 participants and 11 coaches involved PRODEMOS trial. This trial investigated whether a coach-supported mHealth application intervention can reduce people aged 55-75...

10.7189/jogh.15.04036 article EN cc-by Journal of Global Health 2025-03-28

Introduction Profiles of high risk for future dementia are well understood and likely to concern mostly those in low-income middle-income countries people at greater disadvantage high-income countries. Approximately 30%–40% cases have been estimated be attributed modifiable factors, including hypertension, smoking sedentary lifestyle. Tailored interventions targeting these factors can potentially prevent or delay the onset dementia. Mobile health (mHealth) improves accessibility such...

10.1136/bmjopen-2021-049762 article EN cc-by BMJ Open 2021-06-01

Low values of blood pressure, body mass index (BMI), and non-high-density lipoprotein (HDL) cholesterol have all been associated with increased dementia risk in late life, but whether these factors an additive effect is unknown. This study assessed a combination late-life low for systolic pressure (SBP), BMI, non-HDL higher than individual factors.This post hoc analysis based on observational extended follow-up the Prevention Dementia by Intensive Vascular Care (preDIVA) trial, including...

10.1212/wnl.0000000000200954 article EN cc-by-nc-nd Neurology 2022-08-02

Background: Mobile health (mHealth) has the potential to bring preventive healthcare within reach of populations with limited access services, by delivering personalized support at low cost. Although numerous mHealth interventions are available, very few have been developed following an evidence-based rationale or tested for efficacy. This article describes systematic development a coach-supported application improve healthy lifestyles prevention dementia and cardiovascular disease in United...

10.3389/fneur.2021.733878 article EN cc-by Frontiers in Neurology 2021-12-16

Individuals with a low socioeconomic status (SES) have an increased risk of cardiovascular disease (CVD) and dementia, partly due to the high prevalence unhealthy behaviours in this population. Interventions targeting lifestyle-related factors can potentially delay or prevent CVD dementia onset. In study, we explore attitudes, experiences views SES older adults on healthy lifestyles for prevention dementia. We also aim study potential role coach-supported mobile health (mHealth) use,...

10.1136/bmjopen-2021-055984 article EN cc-by-nc BMJ Open 2022-02-01

Objectives Over the coming decades, China is expected to face largest worldwide increase in dementia incidence. Mobile health (mHealth) may improve accessibility of prevention strategies, targeting lifestyle-related risk factors. Our aim explore needs and views Chinese older adults regarding healthy lifestyles prevent cardiovascular disease (CVD) through mHealth, supporting Prevention Dementia using Phone Applications (PRODEMOS) study. Design Qualitative semi-structured interview study,...

10.1136/bmjopen-2022-061111 article EN cc-by-nc BMJ Open 2022-11-01

Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), including receptor blockers (ARBs) and dihydropyridine calcium channel (CCBs), has been associated with lower dementia risk. Previous studies had relatively short follow-up periods. The aim this study is to investigate if these effects are sustained over longer periods.This post hoc observational analysis was based on data from a prevention trial (preDIVA its extension), among Dutch community-dwelling older adults...

10.1097/hjh.0000000000003324 article EN cc-by Journal of Hypertension 2022-11-17

<sec> <title>BACKGROUND</title> China is expected to face among the largest increase of people with dementia worldwide in coming decades, seriously challenging Chinese healthcare system. Approximately 40% all cases might be attributable potentially modifiable risk factors, suggesting potential delay or prevent when targeting these factors. Mobile health (mHealth) may improve accessibility such prevention strategies China, given wide and increasing use smartphones by entire population,...

10.2196/preprints.27684 preprint EN 2021-02-03

Eggink, E.; Gerritsen, M. J.A.S.; Eberl, S.; Hollmann, W.; Preckel, B. Author Information

10.1097/00003643-201406001-00717 article EN European Journal of Anaesthesiology 2014-06-01

Abstract Background The rising prevalence of dementia will largely occur in low‐ and middle‐income countries. Up to 30% all cases may be attributable potentially modifiable risk factors. Therefore, lifestyle interventions targeting these factors can prevent or delay the onset dementia. Mobile Health (mHealth) a suitable way improve accessibility such prevention strategies vulnerable hard reach populations. We investigate implementation effectiveness an interactive, coach‐supported mHealth...

10.1002/alz.043039 article EN Alzheimer s & Dementia 2020-12-01

Abstract Background Midlife hypertension is a risk factor for all‐cause dementia. Treatment of with antihypertensive medication (AHM) may therefore be promising strategy to delay or prevent Recent reports have suggested that AHM are associated differential effects on dementia risk, due class‐specific mechanisms. In this study, we assess the association between different AHM‐classes and incident dementia, using data from preDIVA observational extension (POE) study. Method All participants who...

10.1002/alz.052065 article EN Alzheimer s & Dementia 2021-12-01
Coming Soon ...